TY - JOUR T1 - When the Guillain-Barré patient fails to respond to treatment JF - Practical Neurology JO - Pract Neurol SP - 227 LP - 230 DO - 10.1136/jnnp.2009.176578 VL - 9 IS - 4 AU - J B Winer Y1 - 2009/08/01 UR - http://pn.bmj.com/content/9/4/227.abstract N2 - Most patients with Guillain-Barré syndrome (GBS) respond to treatment with intravenous immunoglobulin, but it is not uncommon for some to continue to deteriorate for a period after treatment has been started. This may reflect the natural history of the disease, or an error in diagnosis. This article reflects my own view of what to do in this situation, with a review of what few data there are to guide decision making. ER -